Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma.

Created on 08 Nov 2026

Authors

Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, Mark R Tanner, Sohaib Irfan, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Guilin Tang, Asad A Haider, Yosra Aljawai, Partow Kebriaei, Krina K Patel, Christine Ye, Sheeba K Thomas, Robert Z Orlowski, Richard E Champlin, Elizabeth J Shpall, Muzaffar H Qazilbash

Published in

Transplantation and cellular therapy. Nov 07, 2026. Epub Nov 07, 2026.

PMID:
42998840
Bibliographic data and abstract were imported from PubMed on 08 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement